These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 2279527)
1. Impaired production of interleukin-2(IL2) in patients with Graves' disease by newly developed IL2 radioimmunoassay. Hirooka Y; Ohtake K; Nogimori T; Mitsuma T Exp Clin Endocrinol; 1990 Sep; 96(1):64-72. PubMed ID: 2279527 [TBL] [Abstract][Full Text] [Related]
2. Deregulated production of interleukin-8 (IL-8) in autoimmune thyroid disease studied by newly developed IL-8 radioimmunoassay. Hirooka Y; Mitsuma T; Nogimori T; Ishizuki Y Endocr Regul; 1993 Mar; 27(1):11-5. PubMed ID: 8003701 [TBL] [Abstract][Full Text] [Related]
3. Deregulated production of interleukin-4 (IL4) in autoimmune thyroid disease assayed with a new radioimmunoassay. Hirooka Y; Kayama M; Ohga S; Kimura M; Hasegawa M; Shin K; Nogimori T; Ishizuki Y; Mitsuma T Clin Chim Acta; 1993 Jul; 216(1-2):1-10. PubMed ID: 8222259 [TBL] [Abstract][Full Text] [Related]
4. Development and use of a radioimmunoassay for human interleukin-1 beta. Lisi PJ; Chu CW; Koch GA; Endres S; Lonnemann G; Dinarello CA Lymphokine Res; 1987; 6(3):229-44. PubMed ID: 3498100 [TBL] [Abstract][Full Text] [Related]
5. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. Kasahara T; Djeu JY; Dougherty SF; Oppenheim JJ J Immunol; 1983 Nov; 131(5):2379-85. PubMed ID: 6195261 [TBL] [Abstract][Full Text] [Related]
6. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease. Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404 [TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor in sera of patients with Graves' disease. Balázs C; Farid NR Acta Med Hung; 1991; 48(1-2):3-11. PubMed ID: 1813855 [TBL] [Abstract][Full Text] [Related]
8. Effects of interleukins on EGF-stimulated growth promotion in human thyroid cells: differential modifications by IL-2 and IL-6 in Graves' and normal thyroid cells. Shimomura N; Itoh M; Okugawa T; Murata Y; Seo H Endocr Regul; 1994 Jun; 28(2):55-65. PubMed ID: 7949016 [TBL] [Abstract][Full Text] [Related]
9. Analysis of cellular immunity in patients with Graves' disease. Takaishi M; Kobuke K; Akiyama M; Hara H; Yamakido M Hiroshima J Med Sci; 1990 Dec; 39(4):109-13. PubMed ID: 2086560 [TBL] [Abstract][Full Text] [Related]
10. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. Le JM; Vilcek J J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705 [TBL] [Abstract][Full Text] [Related]
11. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease. Izumi M; Larsen PR J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211 [TBL] [Abstract][Full Text] [Related]
12. Studies of human peripheral blood mononuclear cells (PBMC) from patients with subacute thyroiditis in severe combined immunodeficient (SCID) mice: less production of human interferon gamma than that seen for Graves' disease. Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Miller N; Volpé R Horm Metab Res; 1994 Sep; 26(9):419-23. PubMed ID: 7835825 [TBL] [Abstract][Full Text] [Related]
13. T cell triggering by lectins. I. Requirements for interleukin 2 production; lectin concentration determines the accessory cell dependency. Roosnek EE; Brouwer MC; Aarden LA Eur J Immunol; 1985 Jul; 15(7):652-6. PubMed ID: 3874077 [TBL] [Abstract][Full Text] [Related]
15. Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications. Kitas GD; Salmon M; Farr M; Gaston JS; Bacon PA Clin Exp Immunol; 1988 Aug; 73(2):242-9. PubMed ID: 2972426 [TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin 1 receptors on human peripheral T cells. Shirakawa F; Tanaka Y; Ota T; Suzuki H; Eto S; Yamashita U J Immunol; 1987 Jun; 138(12):4243-8. PubMed ID: 2953802 [TBL] [Abstract][Full Text] [Related]
17. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease. Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746 [TBL] [Abstract][Full Text] [Related]
18. Analysis of T cell-replacing factor-like activity: potent induction of T helper activity for human B cells by residual concanavalin A and interleukin 2. Sauerwein RW; Van der Meer WG; Aarden LA Eur J Immunol; 1987 Aug; 17(8):1145-50. PubMed ID: 2957215 [TBL] [Abstract][Full Text] [Related]
19. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice. Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039 [TBL] [Abstract][Full Text] [Related]
20. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]